Evidence of shared transcriptomic dysregulation of HNRNPU-related disorder between human organoids and embryonic mice.
Ontology highlight
ABSTRACT: Generating effective therapies for neurodevelopmental disorders has remained elusive. An emerging drug discovery approach for neurodevelopmental disorders is to characterize transcriptome-wide dysregulation in an appropriate model system and screen therapeutics based on their capacity to restore functionally relevant expression patterns. We characterized transcriptomic dysregulation in a human model of HNRNPU-related disorder to explore the potential of such a paradigm. We identified widespread dysregulation in functionally relevant pathways and then compared dysregulation in a human model to transcriptomic differences in embryonic and perinatal mice to determine whether dysregulation in an in vitro human model is partially replicated in an in vivo model of HNRNPU</
SUBMITTER: Ressler AK
PROVIDER: S-EPMC9804147 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA